Title
Use of antirheumatic drugs in covid-19 from hydroxychloroquine to anakinra through tocilizumab and baricitinib: A review of the literature
Other title
[Uso de antirreumáticos en covid-19 desde la hidroxicloroquina hasta la anakinra pasando por tocilizumab y baricitinib: Una revisión de la literatura]
Date Issued
31 March 2021
Access level
open access
Resource Type
review
Author(s)
Publisher(s)
Medical Body of the Almanzor Aguinaga Asenjo National Hospital
Abstract
We are currently in a global pandemic caused by the coronavirus 2019 or COVID- 19, presenting different challenges for the health system due to the fact that there is still no vaccine or a treatment that has proven its effectiveness in its entirety, being the management current preventive and supportive. Therefore, this review will study the most prominent antirheumatic drugs that have a probable pharmacological effect, such as hydroxychloroquine, tocilizumab, anakinra and baricitinib, against COVID-19. It is expected that they will provide support for future treatments. and research on the disease.
Start page
52
End page
63
Volume
14
Issue
1
Language
Spanish
OCDE Knowledge area
Reumatología
Subjects
Scopus EID
2-s2.0-85119176002
Source
Revista del Cuerpo Medico Hospital Nacional Almanzor Aguinaga Asenjo
ISSN of the container
22255109
Sources of information:
Directorio de Producción Científica
Scopus